Tumor cells universally expressed CD20 (Figures 1A, B), with frequent positivity for CD19 (95.7%), CD79a (100%), MUM1 (83.8%), and BCL2 (92.1%), while CD10 (17.5%) and CD30 (10%) were less common. This evidence concerns the gene BCL2 and neoplasm.